Argus Upgrades Eli Lilly (LLY) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,425.63 +1.15%
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
31 Buy, 4 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Argus upgraded Eli Lilly (NYSE: LLY) from Hold to Buy.
For more ratings news on Eli Lilly click here and for the rating history of Eli Lilly click here.
Shares of Eli Lilly closed at $35.64 yesterday.
For more ratings news on Eli Lilly click here and for the rating history of Eli Lilly click here.
Shares of Eli Lilly closed at $35.64 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Argus Upgrades Fiserv (FISV) to Buy
- Gordon Haskett Upgrades Wayfair (W) to Buy (1)
- Harmony Biosciences posts Q3 revenue of $269M, reaffirms 2026 outlook
Create E-mail Alert Related Categories
UpgradesRelated Entities
ArgusSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
